| Financial Year |
March 31 2023 |
| Monetary Funds |
339,816,390.04 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
156,156,126.80 |
| Advances to Suppliers |
3,598,808.99 |
| Other Receivables |
3,164,189.21 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
99,962,983.24 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,184,677.15 |
| Total Current Assets |
633,036,114.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
27,303,483.79 |
| Fixed Assetes |
288,265,071.69 |
| Under-construction Projects |
6,109,798.36 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
76,326,118.30 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
326,646.34 |
| Deferred Income Tax Assets |
3,533,631.41 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
401,864,749.89 |
| Total Assets |
1,034,900,864.09 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
36,231,400.00 |
| Accounts Payable |
135,410,252.24 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
54,909,103.11 |
| Taxes Payable |
12,894,707.02 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
35,034,060.36 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
8,330,120.28 |
| Sub-Total of Current Liabilities |
289,305,345.61 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
407,894.83 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,945,874.24 |
| Total Liabilities |
292,251,219.85 |
| Paid-In Capital(Or Share Stock) |
850,870,049.00 |
| Capital Surplus |
3,024,174,478.73 |
| Surplus Reserve |
57,325,565.03 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-3,189,720,448.52 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
742,649,644.24 |
| Owner's Equity（Stockholder's Equity） |
742,649,644.24 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,034,900,864.09 |
